0

Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®

Author: 
Genzyme
Category: Archive
Published
January 19, 2011

Genzyme today announced that it will build an additional manufacturing plant in Geel, Belgium, to support the long-term growth of Myozyme® and Lumizyme® for Pompe disease. The company held a ceremony today in Geel to mark the start of construction of the new €250 million plant, which will include 8,000 liters of production capacity, a complete purification installation, and ample room for additional future capacity expansions. Commercial approvals for the new site are expected to start late 2014.

Back to news articles